Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02905357 · ClinicalTrials.gov registry record
Heart Attack Research Program- Imaging Study
A clinical trial of Myocardial Infarction, sponsored by NYU Langone Health.
- Active
- Registry status
- 450
- Enrollment target
- 20
- Study locations
NCT02905357: Active study of Myocardial Infarction, sponsored by NYU Langone Health.
NCT02905357 is a study of Myocardial Infarction that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 450 participants, below the 4,675-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (90% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02905357, a study of Myocardial Infarction, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 20
- Study locations
Study Summary
The HARP study is a multi-center, diagnostic observational study employing standardized imaging protocols in patients with MINOCA (MI with Non Obstructive Coronary Arteries) to determine the underlying diagnosis in each participant. Participants will be followed for recurrent clinical events, every 6 months, for a maximum of 10 years.
Conditions Studied
Interventions
- DEVICE OCT
- OTHER CMR
Study Locations (20)
California
- Cedars-Sinai Medical Center - Los Angeles
- UC San Diego Medical Center - San Diego
- Stanford University - Stanford
New York
- NYU Winthrop - Mineola
- NYU Langone Medical Center - New York
- Columbia University Medical Center/NYPH - New York
Pennsylvania
- St. Luke's University Health Network - Bethlehem
- University of Pittsburgh Medical Center - Pittsburgh
Alabama
- University of Alabama-Birmingham - Birmingham
Florida
- University of Florida Medical Center - Gainesville
Georgia
- Emory University - Atlanta
Maryland
- Johns Hopkins Medical Center - Baltimore
New Hampshire
- Dartmouth-Hitchcock - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2016-09-12 |
| Est. Completion | 2027-06-30 |
What the registry record for NCT02905357 still lists
NCT02905357 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 4,675-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Myocardial Infarction appearing as the primary indexed condition, and to 2 interventions - of which OCT is the first listed.
NCT02905357 names 20 study sites across 15 states, led by California, New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02905357 about?
NCT02905357 is a clinical study titled "Heart Attack Research Program- Imaging Study". The HARP study is a multi-center, diagnostic observational study employing standardized imaging protocols in patients with MINOCA (MI with Non Obstructive Coronary Arteries) to determine the underlying diagnosis in each participant. Participants will be followed for recurrent clinical events, every ...
What is the current status of trial NCT02905357?
This trial is currently active not recruiting. The enrollment target is 450 participants. The study started on 2016-09-12. Estimated completion is 2027-06-30.
What conditions does trial NCT02905357 study?
This clinical trial studies the following conditions: Myocardial Infarction.
What interventions are being tested in trial NCT02905357?
The interventions under investigation include: OCT (DEVICE), CMR (OTHER).
Who is sponsoring clinical trial NCT02905357?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02905357 being conducted?
This trial has 20 study locations across Alabama, California, Florida, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02905357's enrollment target sits among peer trials
450 28th of 64 higher than 37 of 64 other Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
Women's Heart Attack Research Program: Stress Ancillary Study
RECRUITING · NA
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RECRUITING
-
Heart Attack Research Program: Platelet Sub-Study (HARP)
RECRUITING
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI